Safety and Immunogenicity of the 'EuPCV15' in Healthy Korean Adults

NCT04830358 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumococcal Disease

Interventions

BIOLOGICAL: EuPCV15
BIOLOGICAL: Prevenar13

Sponsor

EuBiologics Co.,Ltd